Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 14 studies | 25% ± 8% | |
fibroblast | 10 studies | 20% ± 5% | |
endothelial cell of vascular tree | 7 studies | 25% ± 8% | |
pericyte | 5 studies | 20% ± 2% | |
B cell | 4 studies | 21% ± 2% | |
endothelial cell of artery | 4 studies | 18% ± 3% | |
vein endothelial cell | 4 studies | 29% ± 13% | |
naive B cell | 4 studies | 19% ± 3% | |
glutamatergic neuron | 4 studies | 31% ± 12% | |
epithelial cell | 3 studies | 40% ± 17% | |
ciliated cell | 3 studies | 27% ± 8% | |
basal cell | 3 studies | 19% ± 3% | |
GABAergic neuron | 3 studies | 28% ± 9% | |
interneuron | 3 studies | 26% ± 7% | |
oligodendrocyte | 3 studies | 21% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 26% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1999.74 | 1443 / 1445 | 100% | 22.54 | 183 / 183 |
prostate | 100% | 3482.16 | 245 / 245 | 99% | 33.56 | 499 / 502 |
ovary | 100% | 2966.83 | 180 / 180 | 99% | 17.97 | 427 / 430 |
breast | 100% | 4637.42 | 459 / 459 | 99% | 25.37 | 1108 / 1118 |
lung | 99% | 2518.63 | 575 / 578 | 99% | 19.50 | 1145 / 1155 |
pancreas | 100% | 2693.32 | 328 / 328 | 98% | 19.05 | 175 / 178 |
stomach | 100% | 2094.93 | 359 / 359 | 98% | 14.10 | 281 / 286 |
thymus | 100% | 3175.93 | 653 / 653 | 98% | 32.44 | 593 / 605 |
brain | 99% | 1363.45 | 2623 / 2642 | 99% | 12.92 | 696 / 705 |
uterus | 100% | 2763.53 | 170 / 170 | 98% | 17.42 | 448 / 459 |
intestine | 100% | 2033.42 | 966 / 966 | 97% | 13.90 | 511 / 527 |
skin | 100% | 2736.13 | 1808 / 1809 | 95% | 15.64 | 448 / 472 |
kidney | 100% | 2048.70 | 89 / 89 | 95% | 16.21 | 854 / 901 |
bladder | 100% | 2178.14 | 21 / 21 | 92% | 11.96 | 464 / 504 |
adrenal gland | 100% | 1680.99 | 258 / 258 | 89% | 8.89 | 204 / 230 |
liver | 90% | 699.28 | 203 / 226 | 66% | 5.45 | 268 / 406 |
adipose | 100% | 3882.46 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3717.36 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1497.17 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 100% | 1866.57 | 799 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 17.06 | 44 / 45 |
heart | 97% | 1546.89 | 834 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 16.00 | 75 / 80 |
lymph node | 0% | 0 | 0 / 0 | 66% | 6.88 | 19 / 29 |
peripheral blood | 22% | 423.46 | 201 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050673 | Biological process | epithelial cell proliferation |
GO_0030216 | Biological process | keratinocyte differentiation |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0035329 | Biological process | hippo signaling |
GO_0060044 | Biological process | negative regulation of cardiac muscle cell proliferation |
GO_1902174 | Biological process | positive regulation of keratinocyte apoptotic process |
GO_2000036 | Biological process | regulation of stem cell population maintenance |
GO_0050680 | Biological process | negative regulation of epithelial cell proliferation |
GO_0097283 | Biological process | keratinocyte apoptotic process |
GO_0060038 | Biological process | cardiac muscle cell proliferation |
GO_0050821 | Biological process | protein stabilization |
GO_0045600 | Biological process | positive regulation of fat cell differentiation |
GO_0060412 | Biological process | ventricular septum morphogenesis |
GO_0001942 | Biological process | hair follicle development |
GO_0060575 | Biological process | intestinal epithelial cell differentiation |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0060487 | Biological process | lung epithelial cell differentiation |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0043539 | Molecular function | protein serine/threonine kinase activator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SAV1 |
Protein name | Protein salvador homolog 1 (45 kDa WW domain protein) (hWW45) Salvador family WW domain containing protein 1 |
Synonyms | WW45 |
Description | FUNCTION: Regulator of STK3/MST2 and STK4/MST1 in the Hippo signaling pathway which plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS1/2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. SAV1 is required for STK3/MST2 and STK4/MST1 activation and promotes cell-cycle exit and terminal differentiation in developing epithelial tissues. Plays a role in centrosome disjunction by regulating the localization of NEK2 to centrosomes, and its ability to phosphorylate CROCC and CEP250. In conjunction with STK3/MST2, activates the transcriptional activity of ESR1 through the modulation of its phosphorylation. . |
Accessions | H0YJT4 ENST00000557458.1 H0YJH0 H0YJ02 ENST00000324679.5 ENST00000553731.1 ENST00000555720.5 Q9H4B6 G3V453 ENST00000556735.1 |